Challenging anticoagulation decisions in atrial fibrillation: a narrative review [0.03%]
心房颤动抗凝难点及对策——综述
Michael Griffin,Riccardo Proietti,Gregory Y H Lip et al.
Michael Griffin et al.
Atrial fibrillation (AF) is common and warrants consideration of oral anticoagulant (OAC) medication. Usually, the decision is straightforward, following the pathway outlined in the European Society of Cardiology's guideline; however, certa...
Empagliflozin and other SGLT2 inhibitors in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis [0.03%]
心力衰竭合并射血分数保留患者的恩格列净及其他SGLT2抑制剂：系统评价和meta分析
Abdulrahman Khaldoon Hamid,AbdulJaber A&#x;Ed Tayem,Sandra Thair Al-Aish et al.
Abdulrahman Khaldoon Hamid et al.
Background: Heart failure (HF) is a highly prevalent disease, among the primary factors contributing to morbidity and death. One of its types is heart failure with preserved ejection fraction (HFpEF) comprising 40%-50% of...
Vascular-endothelial adaptations following low and high volumes of high-intensity interval training in patients after myocardial infarction [0.03%]
心肌梗死后患者进行高低不同负荷高强度间歇训练后血管内皮的适应性反应
Rodrigo Aispuru-Lanche,Jon Ander Jayo-Montoya,Sara Maldonado-Martín
Rodrigo Aispuru-Lanche
Background: Determinants of coronary artery disease, such as endothelial dysfunction and oxidative stress, could be attenuated by high-intensity aerobic interval exercise training (HIIT). However, the volume of this type ...
Randomized Controlled Trial
Therapeutic advances in cardiovascular disease. 2024 Jan-Dec:18:17539447241286036. DOI:10.1177/17539447241286036 2024
Quantifying the 'distance to LDC-goal' in patients at very high cardiovascular risk with hyperlipidaemia in Germany: a retrospective claims database analysis [0.03%]
德国高心血管风险的高脂血症患者的"LDC 目标达标距离"的量化研究：一项基于回顾性理赔数据库的分析
Ksenija Stach,Hartmut Richter,Uwe Fraass et al.
Ksenija Stach et al.
Background and objectives: This study quantified the 'distance to LDL-C goal' in patients at very high cardiovascular risk with uncontrolled hyperlipidaemia. 'Distance to LDL-C goal' was defined as the percentage by which...
Unlocking the potential of deferoxamine: a systematic review on its efficacy and safety in alleviating myocardial ischemia-reperfusion injury in adult patients following cardiopulmonary bypass compared to standard care [0.03%]
脱氧氨基乙酸改善体外循环心脏手术后心肌缺血再灌注损伤的疗效和安全性的系统评价研究
Aashish Lamichhane,Sadish Sharma,Bishwas Bastola et al.
Aashish Lamichhane et al.
Background: Reperfusion injury, characterized by oxidative stress and inflammation, poses a significant challenge in cardiac surgery with cardiopulmonary bypass (CPB). Deferoxamine, an iron-chelating compound, has shown p...
Gowri Kiran Puvvala,Anastasios Psyllas,Jürgen Hinkelmann et al.
Gowri Kiran Puvvala et al.
Acute limb ischemia (ALI) due to arterial thromboembolic occlusion is a critical emergency in vascular medicine, requiring attention for rapid diagnosis and intervention, to prevent limb loss and major amputation, which is associated with p...
Coronary intravascular lithotripsy in contemporary practice: challenges and opportunities in coronary intervention [0.03%]
冠脉血管内碎石术在当代实践中的挑战与机遇——冠心病介入治疗的新思考
Ankush Gupta,Abhinav Shrivastava,Jaskaran Singh Dugal et al.
Ankush Gupta et al.
Percutaneous coronary intervention (PCI) of calcified coronary arteries is associated with poor outcomes. Poorly modified calcified lesion hinders the stent delivery, disrupts drug-carrying polymer, impairs drug elution kinetics and results...
Inhibitory effect of microRNA-21 on pathways and mechanisms involved in cardiac fibrosis development [0.03%]
微小核糖核酸-21通过抑制相关信号通路及机制对心肌纤维化形成的影响作用研究
Amirreza Khalaji,Saba Mehrtabar,Armin Jabraeilipour et al.
Amirreza Khalaji et al.
Cardiac fibrosis is a pivotal cardiovascular disease (CVD) process and represents a notable health concern worldwide. While the complex mechanisms underlying CVD have been widely investigated, recent research has highlighted microRNA-21's (...
Gene polymorphism as a cause of hemorrhagic complications in patients with non-valvular atrial fibrillation treated with oral vitamin K-independent anticoagulants [0.03%]
口服维生素K无关抗凝药治疗非瓣膜性房颤患者出血并发症的基因多态性病因研究
Ayan Abdrakhmanov,Aizhana Shaimerdinova,Zhanasyl Suleimen et al.
Ayan Abdrakhmanov et al.
Atrial fibrillation (AF) accounts for 40% of all cardiac arrhythmias and is associated with a high risk of stroke and systemic thromboembolic complications. Dabigatran, rivaroxaban, apixaban, and edoxaban are direct oral anticoagulants (DOA...
Use of coronary artery calcium score and coronary CT angiography to guide cardiovascular prevention and treatment [0.03%]
冠状动脉钙化评分和冠状动脉CT血管造影在心血管预防和治疗中的应用
Maria Rita Lima,Pedro M Lopes,António M Ferreira
Maria Rita Lima
Currently, cardiovascular risk stratification to guide preventive therapy relies on clinical scores based on cardiovascular risk factors. However, the discriminative power of these scores is relatively modest. The use of coronary artery cal...